Rohit Lakhanpal, MD
Retina Specialist · Owings Mills, MDNPI 1104870401
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $102,354 of the $167,784 with a category attached, or 61.0%. 18 manufacturers reported payments, led by Novartis at 44.2% of the total. Among retina specialist clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $647.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$74K
- Astellas Pharma US Inc$53K
- Regeneron Healthcare Solutions, Inc.$24K
- Regeneron$8K
- Genentech USA, Inc.$4K
- Apellis Pharmaceuticals, Inc.$3K
- plus $3K from 12 others
What the payments were for
- Consulting fees$45,27727%
- Speaking & faculty fees$102,35461%
- Travel & lodging$12,0507%
- Food & beverage$8,1025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 51 | $74,131 |
| Astellas Pharma US Inc | 50 | $52,561 |
| Regeneron Healthcare Solutions, Inc. | 49 | $23,548 |
| Regeneron | 5 | $7,609 |
| Genentech USA, Inc. | 18 | $3,519 |
| Apellis Pharmaceuticals, Inc. | 20 | $3,003 |
| AbbVie(2 entities) | 42 | $1,217 |
| Dutch Ophthalmic, USA | 1 | $840 |
| Genentech, Inc. | 4 | $452 |
| Alcon | 3 | $396 |
| Eyepoint US, Inc. | 3 | $178 |
| Alimera Sciences, Inc. | 6 | $120 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Bausch & Lomb Americas Inc. | 2 | $43 |
| Sandoz | 1 | $32 |
| Coherus Oncology, Inc. | 1 | $28 |
| Astellas Pharma Global Development | 1 | $22 |
| Vyera Pharmaceuticals, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$167,784 in reported general payments places this provider in the 95th percentile of 47 retina specialist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 30 | $1,348 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 13 | $92 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Owings Mills
- Brian DoChevy Chase$116K
- Adam GerstenblithHagerstown$107K
- Aziz KhanifarSilver Spring$83K
- Michael ElmanBaltimore$27K
- Reginald SandersGreenbelt$24K
- Sidney SchechetBaltimore$23K
- Mohsin AliGreenbelt$14K
- Michael LaiChevy Chase$13K
- Robert ParnesHagerstown$7K
- Lisa SchocketBaltimore$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.